Speaker illustration

Doctor Jorg Taubel

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Dr Jorg Taubel is medical practitioner and CEO of Richmond Pharmacology, a centre of excellence for experimental medicine studies, which he co-founded in 2001. A specialist in clinical pharmacology, Dr Taubel has extensive experience in cardiology, neurology, gastroenterology, and ethnic bridging studies. He was Principal Investigator in over 500 clinical trials in Phases 1 – 3. He is an MHRA recognised investigator for First in Human trials involving healthy and/or patient participants.

Novel antisense therapy targeting microRNA-132 in patients with heart failure

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Cutting-edge clinical investigations in heart failure


Effects of the fluoroquinolones moxifloxacin and levofloxacin on the QT subintervals: sex differences in ventricular repolarization

Event: ESC Congress 2019

Topic: Cardiotoxicity of Drugs

Session: Cardiovascular pharmacotherapy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb